@LaurusLabs I don’t deserve any credit. It was your hard earned capital. You took the risk.
Business has performed due to best in class management, capabilities, capacities, patents and scientific talent that Laurus has accumulated over the years. Best is ahead 🤞🤞
More from Sajal Kapoor
You offer me 80% cost arbitrage (discount relative to Japan/EU/US) along with low confidence / assurance on Critical Success Factors and I won't give you a single NCE/NBE to discover, develop or manufacture. Capex/opex arbitrage is too low in the disruptive-science-pecking-order! https://t.co/O2l8dK4BUv
@unseenvalue Given high capex/opex cost structures of US/Japan/EU, how will they be able to compete with Indian API companies? https://t.co/OYhC2PUZpL
— Hiren (@hiren_investing) August 11, 2021
More from Lauruslabs
LAURUSLABS
Haters are gonna hate, but IMO, this is the best opportunity to start pyramiding and make it a well sized holding.
A trio of patterns coming together, has one of the highest success rate!
Double Top Buy, T20 Pattern - Bullish & Super pattern - Bullish above 477.81! https://t.co/SqzkTyb9wx
Haters are gonna hate, but IMO, this is the best opportunity to start pyramiding and make it a well sized holding.
A trio of patterns coming together, has one of the highest success rate!
Double Top Buy, T20 Pattern - Bullish & Super pattern - Bullish above 477.81! https://t.co/SqzkTyb9wx
LAURUSLABS
— Saket Reddy (@saketreddy) December 17, 2020
There was no entry in Oct as the stock didn't close above 340.
Don't chase & don't buy it for short term.
Now, DTB above 348.15 daily close (Now trading at similar levels).
Wait for close above it or check if it's above the trigger price after 15:20 and enter. https://t.co/vh5hZpjJER pic.twitter.com/EprcgeLSqb
You May Also Like
Moderna CEO Stephane Bancel was previously CEO of bioMerieux in France from 07-10.
Alain Merieux, who owns bioMerieux, was instrumental in the creation of the Wuhan Institute of Virology P4 Lab.
The same people who helped create the virus, also helped to create the vaccines...
Moderna partnered with French Pasteur Institute in 2015 to develop mRNA vaccine technology.
Pasteur Institute partnered with the Wuhan P4 Laboratory in 2017 along with the Merieux Foundation to study emerging viruses...
https://t.co/yFsHwrNYaK
https://t.co/9M5lydBKhM
Nobel prize winning scientist Luc Montagnier asserts that Sars-Cov-2 is man-made and originated from the Wuhan Institute of Virology.
Montagnier did extensive work with the Pasteur Institute in France which was partnered with the Wuhan P4.
Merieux Foundation & the Chinese government have worked together since 1965, and partnered to study emerging pathogens in Africa in 2015.
Their research included "PATHOGENS CARRIED BY BATS" that provoke respiratory diseases.
🚨🚨🚨
https://t.co/gVwpT0ssqI
Alain Merieux, who owns bioMerieux, was instrumental in the creation of the Wuhan Institute of Virology P4 Lab.
The same people who helped create the virus, also helped to create the vaccines...
Moderna partnered with French Pasteur Institute in 2015 to develop mRNA vaccine technology.
Pasteur Institute partnered with the Wuhan P4 Laboratory in 2017 along with the Merieux Foundation to study emerging viruses...
https://t.co/yFsHwrNYaK
https://t.co/9M5lydBKhM
Nobel prize winning scientist Luc Montagnier asserts that Sars-Cov-2 is man-made and originated from the Wuhan Institute of Virology.
Montagnier did extensive work with the Pasteur Institute in France which was partnered with the Wuhan P4.
Merieux Foundation & the Chinese government have worked together since 1965, and partnered to study emerging pathogens in Africa in 2015.
Their research included "PATHOGENS CARRIED BY BATS" that provoke respiratory diseases.
🚨🚨🚨
https://t.co/gVwpT0ssqI